APA (7th ed.) Citation

SMA, M., P, S., K, E., KH, F., D, C., N, B., & RB, L. (2026). A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemia. Leukemia, 40(7), 1569. https://doi.org/10.1038/s41375-026-02976-5

Chicago Style (17th ed.) Citation

SMA, Mohamed, Schofield P, Evans K, Friedrich KH, Christ D, Bayat N, and Lock RB. "A Novel CRLF2-targeted Antibody-drug Conjugate Exhibits Potent Anti-leukemic Activity Against Ph-like Acute Lymphoblastic Leukemia." Leukemia 40, no. 7 (2026): 1569. https://doi.org/10.1038/s41375-026-02976-5.

MLA (9th ed.) Citation

SMA, Mohamed, et al. "A Novel CRLF2-targeted Antibody-drug Conjugate Exhibits Potent Anti-leukemic Activity Against Ph-like Acute Lymphoblastic Leukemia." Leukemia, vol. 40, no. 7, 2026, p. 1569, https://doi.org/10.1038/s41375-026-02976-5.